Arbor Realty Trust Reports Fourth Quarter and Full Year 2019 Results and Declares Common Stock Dividend
Fourth Quarter Highlights:GAAP net income of $0.34 per diluted common shareAFFO per diluted common share of $0.34, excluding a one-time […]
Quotient Limited Announces CE Mark Approval for Initial Serological Disease Screening Microarray
JERSEY, Channel Islands, Feb. 14, 2020 (GLOBE NEWSWIRE) — Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, […]
Roadman Investments Enters Into Definitive Agreement for Acquisition of CLOV Biopharma Corp.
VANCOUVER, British Columbia, Feb. 14, 2020 (GLOBE NEWSWIRE) — Roadman Investments Corp. (TSXV: LITT)(FWB: 1QD)(OTC: RMANF) (“Roadman Investments” or the […]
Ceapro Inc. Receives Research License from Health Canada Controlled Substances and Cannabis Branch
EDMONTON, Alberta, Feb. 14, 2020 (GLOBE NEWSWIRE) — Ceapro Inc. (TSX-V: CZO; OTCQX:Bay Street News
HCI Group Insurance Subsidiary Enters into Policy Replacement Agreement with Anchor Property & Casualty Insurance Company
TAMPA, Fla., Feb. 14, 2020 (GLOBE NEWSWIRE) — HCI Group, Inc. (NYSE: HCI) announced today that its wholly owned insurance […]
REPEAT – AgraFlora Premium Hemp Brands to List on Amazon and Other Online Retail Channels
VANCOUVER, British Columbia, Feb. 14, 2020 (GLOBE NEWSWIRE) — AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (Frankfurt: PU31) […]
Immunomedics Appoints Dr. Loretta Itri Chief Medical Officer
MORRIS PLAINS, N.J., Feb. 14, 2020 (GLOBE NEWSWIRE) — Immunomedics, Inc. (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical […]
SUMR Brands Restructures Business, Sets Earnings Date
WOONSOCKET, R.I., Feb. 14, 2020 (GLOBE NEWSWIRE) — SUMR Brands (“SUMR Brands” or the “Company”) (NASDAQ: SUMR), a global leader […]
Outlook Therapeutics Provides Business Update and Reports Financial Results for the First Quarter of Fiscal Year 2020
CRANBURY, N.J., Feb. 14, 2020 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK) (the “Company”), a late clinical-stage biopharmaceutical company working to develop […]
Acasti Pharma Provides Business Update for the Third Quarter of Fiscal 2020
LAVAL, Québec, Feb. 14, 2020 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST), […]
